Turing Prize, Dr Yoshua Bengio as well as the curator of the Human Metabolome Database, Dr David Wishart. To fundamentally transform our healthcare systems and improve patient care, we must provide novel, non-invasive and easily accessible modalities for better diagnosis, prediction of health status, optimization of treatments and monitoring. Integrated into the VC fund, Linearis Labs' AI-driven differentiating offering is unique in generating disease signatures tailored to elucidate causal relationships underlying human omics and diseases. Its omic signature AI-tailored approach to cancer, diabetes, infectious diseases, NASH and other chronic diseases will accelerate discovery and commercialize new innovative medicines to improve patient care and outcomes.